<scp><i>WNT5A</i></scp> is a putative epi‐driver of prostate cancer metastasis to the bone
Given the limited effective therapies available for metastatic cancer sufferers, particularly those whose disease has metastasised to the bone, WNT5A presents as a potential putative target for therapy.
Authors
- RC Malley (ORCID: https://orcid.org/0000-0002-3289-5270)
- Kelsie Raspin (ORCID: https://orcid.org/0000-0001-8463-6820)
- Adele F. Holloway (ORCID: https://orcid.org/0000-0003-2213-1717)
- E. J. Wilkinson (ORCID: https://orcid.org/0000-0003-2229-8656)
- Louise M. Nott
- Joanne L. Dickinson (ORCID: https://orcid.org/0000-0003-4621-1703)
- Shaun Donovan
Institutions
- University of Tasmania (AU)
- Royal Hobart Hospital (AU)
- Cancer Council Tasmania (AU)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.70122
- Citations
- 6
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.51
Funders
- Royal Hobart Hospital Research Foundation
- University of Tasmania
- Cancer Council Tasmania